Healthcare -
Biotechnology - NASDAQ - GB
$ 2.86
-1.38 %
$ 443 M
Market Cap
-9.53
P/E
Price Target
Average
153.50%
Revenue Forecast
Estimate
123.06%
EBIT
Estimate
--19.07%
Net Income
Estimate
46.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mereo BioPharma Group plc
Wall Street analysts predict an average 1-year price target for MREO of $7.25 , with forecasts ranging from
a
low of
$6 to a high of $8 .
MREO Lowest Price Target
Wall Street Target
6 USD
109.79%
MREO Average Price Target
Wall Street Target
7.25 USD
153.50%
MREO Highest Price Target
Wall Street Target
8 USD
179.72%
REVENUE FORECAST
Revenue Forecast Chart MREO
EBIT FORECAST
EBIT Forecast Chart MREO
NET INCOME FORECAST
Net Income Chart MREO